Defibrillators Industry Overview

The global defibrillators market size was estimated at USD 7.32 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. Increasing product development activities, rising incidence of sudden cardiac arrest, growing awareness among the general public, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth. In May 2021, Rapid Response Revival Research Ltd.-an Australian company-received a CE mark for its CellAED, the world’s first personal automated external defibrillator (AED) for home use. This supported the company’s growth strategy.

Gather more insights about the market drivers, restrains and growth of the Defibrillators Market

The COVID-19 pandemic adversely impacted the industry, particularly the International Classification of Diseases (ICDs) market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Increasing geriatric population globally and technological advancements are other key factors that are projected to significantly impact market growth. The older population, particularly those aged between 65 years and above, is more vulnerable to chronic diseases, such as cardiovascular diseases (CVDs), which often require the placement of defibrillators to restore a normal heart rhythm by delivering an electric shock to the heart. For instance, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans" reported that around 54.1 million (16.3%) individuals in the U.S. are aged 65 years or above. Thus, the growing geriatric population contributes to the increasing product demand.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global implantable cardioverter defibrillators market size was estimated at USD 3.81 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030.
• The global external defibrillators market size was estimated at USD 3.51 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.

Defibrillators Market Segmentation

Grand View Research has segmented the global defibrillators market on the basis of product, end-use, and region:

Defibrillators Product Outlook (Revenue, USD Million, 2018 - 2030)

• Implantable Cardioverter Defibrillators (ICD)
• S-ICD
• T-ICD
• External Defibrillators (ED)
• Manual ED
• Automated ED
• Wearable Cardioverter Defibrillators

Defibrillators End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital
• Pre-hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

Defibrillators Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Medtronic
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG
• MicroPort Scientific Corporation
• Koninklijke Philips N.V.
• Stryker
• ZOLL Medical Corporation (Asahi Kasei)
• Nihon Kohden Corporation
• Schiller AG

Key Defibrillators Company Insights

The market has been characterized by intense competition. Market players incorporate various strategic initiatives to increase their market share. These include product development, regional expansion, partnerships and collaborations, and mergers & acquisitions. For instance, In August 2022, Medtronic reported the achievement of trial endpoints for its investigational EV ICD (extravascular implantable cardioverter defibrillator) system. This innovative device is designed to mitigate specific risks associated with traditional transvenous ICDs by sitting its lead outside the heart and veins, positioned beneath the sternum, through a minimally invasive approach.

Order a free sample PDF of the Defibrillators Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.